News & Updates
Filter by Specialty:
Prilocaine/lidocaine spray safe, effective in men with premature ejaculation
The eutectic-like mixture of prilocaine/lidocaine spray appears to work well in the treatment of men with various types of premature ejaculation, as reflected by a high treatment adherence, according to data from a real-world study.
Prilocaine/lidocaine spray safe, effective in men with premature ejaculation
05 May 2022Statins confer some protection against breast cancer recurrence in Asians
Taking a statin after breast cancer surgery appears to reduce the risk of disease recurrence in Asians, especially among those with invasive cancers, as shown in a study from Singapore.
Statins confer some protection against breast cancer recurrence in Asians
04 May 2022Nirmatrelvir-ritonavir cuts disease progression, viral load in unvaccinated COVID-19 outpatients
In the phase II/III EPIC-HR* trial, the novel oral antiviral nirmatrelvir-ritonavir reduced the risk of progression of COVID-19 to severe disease, as well as viral load, in symptomatic, high-risk, unvaccinated nonhospitalized adults confirmed to have SARS-CoV-2 infection.
Nirmatrelvir-ritonavir cuts disease progression, viral load in unvaccinated COVID-19 outpatients
04 May 2022New HF guideline: Quad therapy, HFmrEF, and more
Hot on the heels of ACC.22 ground-breaking reports, the ACC/AHA/HFSA* released the 2022 heart failure (HF) guideline, with special emphasis on quad therapy for patients with reduced ejection fraction.
New HF guideline: Quad therapy, HFmrEF, and more
04 May 2022Narrow- vs broad-spectrum antibiotics: Which is better for older AECOPD patients?
Use of either empiric broad- or narrow-spectrum antibiotics in older patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) shows no remarkable difference in the primary outcome, reports a recent study.
Narrow- vs broad-spectrum antibiotics: Which is better for older AECOPD patients?
03 May 2022Baricitinib may improve hair regrowth in alopecia areata
A once-daily dose of oral baricitinib may encourage hair regrowth in patients with severe alopecia areata, according to results of the phase III BRAVE-AA studies presented at AAD 2022.